Hot search: economy  fixed  Laboratory  Service  Port  Electronics  market  third  increase  Testing 
 
Home > News > Market > Content

Immunetics Has Appointed John Yonkin as New CEO

increase font size  reduce font Add date: 2016-11-30  Hits:68
Core prompt: Immunetics,a developer of infectious disease diagnostic tests,has appointed John Yonkin as the company's new chief executive officer(CEO),effective fr

Immunetics,a developer of infectious disease diagnostic tests,has appointed John Yonkin as the company's new chief executive officer(CEO),effective from 1 December 2012.

Prior to joining Immunetics,Yonkin served at Alere as vice president for strategic projects,where he lead the executive responsible for the integration of acquired Biosite company.

From 2001-2005,Yonkin worked at Inverness Medical Innovations as vice president of US sales and marketing and from 2005-2007 served as president of nutritionals and pharmaceuticals.

In addition,Yonkin held various roles including product development,managing sales and marketing at Baxter,Genzyme,and Inverness.

Immunetics CEO John Yonkin said,"I am very excited to be joining the very talented scientific team at Immunetics as the company prepares to bring to market the innovative BacTx rapid test for bacterial contamination of platelets."

The FDA-approved BacTx test addresses global infectious risk in transfusion,caused by the estimated 1 in 2,000 platelet units that are contaminated with bacteria leading to illness and death among recipients.

 
 
[ NewsSearch ]  [ Send Fav ]  [ Share ]  [ Print ]  [ Send Report ]  [ Close ]

 
Total0bar [View All]  Related Comments

 
Photo Recommended
Recommend News
Click Rank
 
Home | Products | Suppliers | News | Tradeshow | Sitemap | Message | RSS Feed